Cyclosporine/Trehalose

环孢素/海藻糖

Report date: 2026/01/21 17:00:52

Base Information

Drug NameCyclosporine/Trehalose
Drug Alias NameCyclosporine/trehaloseTrehalose/CiclosporineTrehalose/CyclosporineCiclosporine/TrehaloseHU-007 +[6] 
ClassificationSmall moleculesSmall molecules > Molecular Glue
Mechanisms of ActionImmunosuppressantsCalcineurin inhibitorsImmunomodulators +[6] 
TargetsCalcineurinMitocliondrial permeability transition poreGlycoproteins +[4] 
Therapy Area/IndicationsDry Eye Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes TrehaloseCyclosporine
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHuons Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuons Co Ltd
Inactive CompaniesN/A
Active IndicationsDry Eye Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A